Event
Cusmedi's PRIMARY SYSTEM is now FDA 510(k) cleared.
2026.11.11

Cusmedi's PRIMARY SYSTEM is now FDA 510(k) cleared. On November 6, 2026, the U.S. FDA cleared our 3D-printed, patient-specific titanium implant system. The clearance covers three models: Cranial reconstruction (PRIMARY), Zygomatic Reconstruction (PRIMARY-Z) and Orbital Reconstruction (PRIMARY-O). We are now ready to work with U.S. hospitals and distribution partners. If you would like to know more, message us or write to world@cusmedi.com. What this means for surgeons in the United States: • Implants designed from each patient's CT data • 3D printed in Ti-6Al-4V ELI, combining continuous and porous structures • Built-in screw positions, with no additional fixation plates • Design review and approval through Dr. Check, our real-time digital workflow platform